1 Jun 2026Open access
Association between PFAS and renal function indicators in cord blood of newborns: modifying effects of newborn sex and maternal factorsAnnals of Medicine, Per- and polyfluoroalkyl substances research
Active, last published 2026
In effects and risks of endocrine disrupting chemicals
Francis Manyori
Bigambo
Scholar“Research focused on Effects and risks of endocrine disrupting chemicals and adjacent fields.”
Claim Your Profile10
H-index
274
Citations
Francis has not officially claimed their profile. If you are Francis, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
rancis Manyori Bigambo is a researcher working on Effects and risks of endocrine disrupting chemicals. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Francis's work has been cited 274 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Effects and risks of endocrine disrupting chemicals×8Air Quality and Health Impacts×5Birth, Development, and Health×5Health, Environment, Cognitive Aging×5Toxic Organic Pollutants Impact×4
04 · Where I am
Affiliations
Affiliation on published researchMuhimbili University of Health and Allied Sciences, TanzaniaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works19 Feb 2026Open access
Factors associated with survival among patients with end-stage kidney disease undergoing hemodialysis in Tanzania: a cohort studyBMC Nephrology, Dialysis and Renal Disease Management
Are you Francis?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required